The Pennsylvania Department of Health reported 3,361 new cases of COVID-19 on Saturday and 132 additional deaths from the disease.

Meanwhile, 1,897 coronavirus patients were hospitalized statewide, 403 of them in intensive-care units — down from 2,061 hospitalizations, with 441 patients in ICUs, a week earlier, state data showed.

In the Pittsburgh area, Allegheny County on Saturday reported 313 new cases of COVID-19 and 11 additional deaths. The fatalities ranged from Feb. 14 to Wednesday, with three of them associated with a long-term care facility, according to the county health department.

The youngest victim was in his or her 60s; the oldest, in his or her 90s.

Advertise with us

Among the newly reported cases, 241 were confirmed from PCR tests, and 72 were probable, according to the county. About half the positive tests were more than a week old.

Those newly reported as COVID-positive ranged in age from 10 months to 91 years, with a median age of 34 years, the county said.

The county has now recorded 76,449 cases of COVID-19 and 1,669 deaths since the coronavirus pandemic began last March. Reported cases statewide have reached 929,697; fatalities, 24,000.

Also Saturday, the state health department said 2.3 million COVID-19 vaccine doses had been administered in Pennsylvania as of Friday. About 1.6 million people in the state had received their first doses of vaccine. Of those, nearly 700,000 had received a second dose and completed the vaccination process.

The vaccination statistics do not include vaccine administered as part of a federal pharmacy partnership, at federal facilities or in Philadelphia, which operates as its own jurisdiction.

Advertise with us

In another pandemic development, research published Thursday indicates that drugs typically used for rheumatoid arthritis may significantly improve survival among critically ill coronavirus patients.

Dr. Christopher Seymour, an associate professor of critical care medicine and emergency medicine at UPMC, co-authored the study, findings from which appear in the New England Journal of Medicine. The drugs have been incorporated at UPMC as a standard treatment for COVID-19 patients with critical disease, Dr. Seymour said in a statement shared by the health system.

Two drugs examined in the study were found to reduce mortality by 8.5% and to improve recovery, according to researchers. On average, severely sick patients receiving the novel treatment could leave the intensive-care unit about a week faster, they found.